Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
55 hedge funds and large institutions have $56M invested in Histogen Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 14 closing their positions.
215% more call options, than puts
Call options by funds: $3.49M | Put options by funds: $1.11M
21% more capital invested
Capital invested by funds: $46.3M → $56M (+$9.71M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 61 → 55 (-6)
39% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 23
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$2.3M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$913K |
| 3 |
BlackRock
New York
|
+$882K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$755K |
| 5 |
KM
Kalos Management
Alpharetta,
Georgia
|
+$146K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.47M |
| 2 |
Goldman Sachs
New York
|
-$1.3M |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$1.08M |
| 4 |
Millennium Management
New York
|
-$1.08M |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$981K |
HSTO Hedge Fund Activity: Q3 2018 in Review
55 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2018, worth a combined $56M — up 21% from $46.3M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HSTO and 8 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 14 added.
The largest buyer was Artal Group, opening a new position worth an estimated $2.3M. The largest seller was Sofinnova Investments, cutting an estimated $1.47M.
- 55 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2018, down from 61 in Q2 2018.
- Funds reported $56M of Histogen Inc. Common Stock stock for Q3 2018, up 21% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q3 2018 and 14 closed out, a net change of -6 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2018 was Artal Group, an estimated $2.3M added.
- The largest Histogen Inc. Common Stock seller in Q3 2018 was Sofinnova Investments, an estimated $1.47M sold.
Based on aggregated 13F filings for Q3 2018.